The isolation, purification and biological activity of a novel antibacterial compound produced by Pseudomonas stutzeri

被引:25
作者
Uzair, Bushra [3 ]
Ahmed, Nuzhat [3 ]
Ahmad, Viqar Uddin [2 ]
Mohammad, Faryal Vali [2 ]
Edwards, David H. [1 ]
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Dept Mol & Cellular Pathol, Dundee DD1 9SY, Scotland
[2] Univ Karachi, HEJ Res Inst Chem, Int Ctr Chem & Biol Sci, Karachi 32, Pakistan
[3] Univ Karachi, Ctr Mol Genet, Karachi, Pakistan
关键词
antibiotic; Pseudomonas sp; antibacterial activity; marine bacteria; zafrin;
D O I
10.1111/j.1574-6968.2007.01036.x
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A novel compound designated zafrin [4 beta-methyl-5, 6, 7, 8 tetrahydro-1 (4 beta-H)-phenanthrenone] was isolated from a crude extract of a marine bacterium identified as Pseudomonas stutzeri. Zafrin showed strong antibacterial activity against both Gram-positive and Gram-negative bacteria. The compound was purified and its structure was elucidated by spectroscopic methods including 1H-nuclear magnetic resonance (NMR), 13C-NMR, 1D-NMR and 2D-NMR spectroscopy. It could be demonstrated that a purified solution of zafrin was active against several human pathogens, including Staphylococcus aureus, and Salmonella typhi. By contrast, zafrin did not inhibit the growth of eukaryotic organisms Candida albicans and Schizosaccharomyces pombe. The minimal inhibitory concentration for Gram-positive bacteria ranged from 50 to 75 mu g mL(-1) and varied between 75 and 125 mu g mL(-1) for Gram-negative bacteria. Zafrin lysed Bacillus subtilis cells grown in an osmotically protected medium, suggesting that it does not act upon the cell wall. Further investigation using B. subtilis indicated that the compound is bactericidal and is likely to target the cell membrane.
引用
收藏
页码:243 / 250
页数:8
相关论文
共 29 条
[1]   Pharmacodynamic analysis of the activity of quinupristin-dalfopristin against vancomycin-resistant Enterococcus faecium with differing MBCs via time-kill-curve and postantibiotic effect methods [J].
Aeschlimann, JR ;
Rybak, MJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) :2188-2192
[2]  
Bernan VS, 1997, ADV APPL MICROBIOL, V43, P57, DOI 10.1016/S0065-2164(08)70223-5
[3]   Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic [J].
Breukink, E ;
Wiedemann, I ;
van Kraaij, C ;
Kuipers, OP ;
Sahl, HG ;
de Kruijff, B .
SCIENCE, 1999, 286 (5448) :2361-2364
[5]   Vancomycin resistance in gram-positive cocci [J].
Courvalin, P .
CLINICAL INFECTIOUS DISEASES, 2006, 42 :S25-S34
[6]   The molecular evolution of methicillin-resistant Staphylococcus aureus [J].
Deurenberg, R. H. ;
Vink, C. ;
Kalenic, S. ;
Friedrich, A. W. ;
Bruggeman, C. A. ;
Stobberingh, E. E. .
CLINICAL MICROBIOLOGY AND INFECTION, 2007, 13 (03) :222-235
[7]   INHIBITORY ACTIVITY OF ANTIBIOTIC-PRODUCING MARINE-BACTERIA AGAINST FISH PATHOGENS [J].
DOPAZO, CP ;
LEMOS, ML ;
LODEIROS, C ;
BOLINCHES, J ;
BARJA, JL ;
TORANZO, AE .
JOURNAL OF APPLIED BACTERIOLOGY, 1988, 65 (02) :97-101
[8]   The Bacillus subtilis DivIVA protein targets to the division septum and controls the site specificity of cell division [J].
Edwards, DH ;
Errington, J .
MOLECULAR MICROBIOLOGY, 1997, 24 (05) :905-915
[9]   MICROBIAL COMPETITION [J].
FREDRICKSON, AG ;
STEPHANOPOULOS, G .
SCIENCE, 1981, 213 (4511) :972-979